In a rat model of diabetes, we investigated whether reduced HIF/VEGF/Akt/eNOS/MMP-9 signaling in the bone marrow may underlie impaired EPCs mobilization in response to AMI as compared to control (non-diabetic) rats. The gene discussed is AKT1; the disease is diabetes mellitus.